Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Health Education & Behavior : the Official Publication of the Society for Public Health Education|December 1, 2007
Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participationChristi A Patten, Carrie Enoch, Caroline C Renner, et al.
Trials|August 31, 2015
Integrating smoking cessation and alcohol use treatment in homeless populations: study protocol for a randomized controlled trialOlamide Ojo-Fati, Florence John, Janet Thomas, et al.
Molecular Genetics and Metabolism|March 6, 2007
The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type IGregory M Pastores, Pamela Arn, Michael Beck, et al.
Clinical Trials (London, England)|December 15, 2011
Designing a smoking cessation intervention for the unique needs of homeless persons: a community-based randomized clinical trialKate Goldade, Guy-Lucien Whembolua, Janet Thomas, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Molecular Genetics and Metabolism Reports|November 24, 2021
A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trialsBarbara K Burton, Anne Skalicky, Christoph Baerwald, et al.
Molecular Genetics and Metabolism|July 26, 2024
Initial results from the PHEFREE longitudinal natural history study: Cross-sectional observations in a cohort of individuals with phenylalanine hydroxylase (PAH) deficiencyShawn E Christ, Georgianne Arnold, Uta Lichter-Konecki, et al.
International Journal of Cancer|June 15, 2019
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patientsFrancesco Sclafani, Sanna Hulkki Wilson, David Cunningham, et al.
British Journal of Cancer|September 22, 2017
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancerFrancesco Sclafani, Gina Brown, David Cunningham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic diseaseFrancesco Sclafani, David Gonzalez de Castro, David Cunningham, et al.
Pageof 7